DoctorDirectory.ai
Menu

Dr. David Schade, MD

Not yet claimed

Lipidologist, Endocrinologist · Physician (MD)

Albuquerque, NM

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you David Schade? Claim this profile.

Physician certified in clinical lipidology by the American Board of Clinical Lipidology in Albuquerque, NM. Lipidologists manage cholesterol, triglycerides, and lipoprotein(a) with guideline-based care.

About Dr. David Schade, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. David S. Schade is an endocrinologist and clinical lipidologist in Albuquerque, New Mexico. He practices at 2211 Lomas Boulevard NE with UNM Medical Group and is affiliated with the University of New Mexico Hospital (https://www.topnpi.com/nm1154337756/dr-david-schade; https://www.healthcare4ppl.com/physician/new-mexico/albuquerque/david-s-schade-1154337756.html). A consumer directory also lists an affiliation with Presbyterian Hospital (https://www.vitals.com/doctors/Dr_David_Schade.html).

He earned his MD from Washington University in 1968, completed his internal medicine residency at the University of New Mexico in 1973, and finished a two-year endocrinology fellowship at the UNM Health Sciences Center in 1975. He joined the UNM endocrinology faculty in 1977. UNM lists him as certified in internal medicine, endocrinology and metabolism, diabetes education, and clinical lipidology (https://hsc.unm.edu/directory/schade-david-e.html).

Much of his public record is in research and teaching. He is Division Chief of Endocrinology and Metabolism and a Distinguished and Regents' Professor of Medicine at the UNM School of Medicine (https://www.pri-med.com/globals/faculty/s/schadedavids). UNM says he has been a principal investigator on multiple large multicenter diabetes and cardiovascular studies, has been continuously funded by the National Institutes of Health, and has hundreds of peer-reviewed publications (https://news.unm.edu/news/dr-david-schade-to-deliver-the-8th-annual-community-engaged-research-lecture; https://hsc.unm.edu/directory/schade-david-e.html). His recent work includes a 2019 paper on reducing cardiovascular risk and a 2024 Circulation report on cardiovascular outcomes in the GRADE type 2 diabetes trial (https://academic.oup.com/jcem/article/104/12/6033/5342943; https://www.doximity.com/pub/david-schade-md).

CMS Open Payments records for 2021 through 2025 show $7,430.37 in industry payments across 5 records, mostly from HRA Pharma ($7,350), with smaller amounts from Abbott Laboratories and Merck Sharp & Dohme. Payments from industry to doctors are common and legal (CMS Open Payments).

Board certifications
UNM lists certification in internal medicine, endocrinology and metabolism, diabetes education, and clinical lipidology. hsc.unm.edu
Division chief and professor
He is Division Chief of Endocrinology and Metabolism and a Distinguished and Regents' Professor of Medicine at the University of New Mexico School of Medicine. pri-med.com
Training at UNM
MD from Washington University in 1968, internal medicine residency at UNM completed in 1973, and a two-year endocrinology fellowship at the UNM Health Sciences Center completed in 1975. hsc.unm.edu
Large diabetes research record
UNM says he has led multiple large multicenter clinical studies in diabetes and cardiovascular research and has been continuously funded as a principal investigator by the National Institutes of Health. news.unm.edu
Recent trial publication
He is a co-author of 'Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes),' published in Circulation in March 2024. doximity.com
Heart risk in diabetes
He co-wrote 'A Simplified Approach to Reducing Cardiovascular Risk' in the Journal of Clinical Endocrinology & Metabolism in December 2019. academic.oup.com
University awards
UNM records list a Regents' Professorship Award in 2013, Distinguished Professor in 2012, and the Fitz List in 2014. vivo.health.unm.edu
2023 research lecture
In April 2023 he delivered UNM's Eighth Annual Community Engaged Research Lecture, 'Save Your Heart, Save Your Life,' on preventing heart disease especially in patients with diabetes. UNM describes the lecture as one of its highest faculty honors. hsc.unm.edu
Industry payments reported
CMS Open Payments lists $7,430.37 in payments across 5 records for 2021 through 2025, with $7,350 from HRA Pharma and smaller amounts from Abbott Laboratories and Merck Sharp & Dohme. openpaymentsdata.cms.gov

Worth knowing

  • Public sources disagree about his medical school and graduation year. UNM's own page says Washington University in 1968, while one directory lists Washington University in 1970 and another lists the University of Washington School of Medicine in 1968. healthgrades.com
  • Publication counts differ between sources: a UNM news article says nearly 700 peer-reviewed publications, while his UNM faculty page says over 600. hsc.unm.edu
  • No public record was found placing him on clinical practice guideline committees or in named leadership offices of professional societies. hsc.unm.edu

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$7,430

5 payments

2021$0
2022$7,350
2023$44
2024$36
2025$0

Top payers

  • HRA Pharma$7,350
  • Abbott Laboratories$44
  • Merck Sharp & Dohme LLC$36

Payment types

  • Consulting Fee$7,350
  • Food and Beverage$44
  • Education$36

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: hsc.unm.edu · vivo.health.unm.edu · topnpi.com · healthcare4ppl.com · pri-med.com · doximity.com · vitals.com · aace.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

  • Internal Med/Endocrinology Msc10 5550

    Albuquerque, NM 87131

    Open in maps
Something wrong with this profile? ·